As suggested in the study that I posted the other day, the placement of the cells is the key. They map the heart to find the tissue that can be saved, that tissue would be very inflamed. Inflation triggers the implanted cells to release factors proventing progressive disease and also dispersing through the body to radically reduce stroke .Would class 3 CHF have lower levels of site inflammation compaird to class 2 CHF?
CLBP same , cells are placed at the point of inflammation , cells release the required goods and we get very significant pain reduction. Just not in those with problems for over 5 years . How much inflammation would be at the injection site after 5 years ?
Good luck all.
Cell Therapy News/Articles, page-13479
-
- There are more pages in this discussion • 4,950 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |